Suppr超能文献

单链 VαVβ T 细胞受体无需与内源性 TCR 链错配即可发挥功能。

Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.

机构信息

Department of Biochemistry, University of Illinois, Urbana, IL 61801, USA.

出版信息

Gene Ther. 2012 Apr;19(4):365-74. doi: 10.1038/gt.2011.104. Epub 2011 Jul 14.

Abstract

Transduction of exogenous T-cell receptor (TCR) genes into patients' activated peripheral blood T cells is a potent strategy to generate large numbers of specific T cells for adoptive therapy of cancer and viral diseases. However, the remarkable clinical promise of this powerful approach is still being overshadowed by a serious potential consequence: mispairing of the exogenous TCR chains with endogenous TCR chains. These 'mixed' heterodimers can generate new specificities that result in graft-versus-host reactions. Engineering TCR constant regions of the exogenous chains with a cysteine promotes proper pairing and reduces the mispairing, but, as we show here, does not eliminate the formation of mixed heterodimers. By contrast, deletion of the constant regions, through use of a stabilized Vα/Vβ single-chain TCR (scTv), avoided mispairing completely. By linking a high-affinity scTv to intracellular signaling domains, such as Lck and CD28, the scTv was capable of activating functional T-cell responses in the absence of either the CD3 subunits or the co-receptors, and circumvented mispairing with endogenous TCRs. Such transduced T cells can respond to the targeted antigen independent of CD3 subunits via the introduced scTv, without the transduced T cells acquiring any new undefined and potentially dangerous specificities.

摘要

将外源 T 细胞受体 (TCR) 基因转导到患者激活的外周血 T 细胞中是一种产生大量特异性 T 细胞以用于癌症和病毒疾病过继治疗的有效策略。然而,这种强大方法的显著临床前景仍因一个严重的潜在后果而黯然失色:外源 TCR 链与内源性 TCR 链的错配。这些“混合”异二聚体可以产生新的特异性,导致移植物抗宿主反应。用半胱氨酸对外源链的 TCR 恒定区进行工程改造可促进正确配对并减少错配,但正如我们在这里所示,它并不能完全消除混合异二聚体的形成。相比之下,通过使用稳定的 Vα/Vβ 单链 TCR(scTv) 删除恒定区可完全避免错配。通过将高亲和力的 scTv 与细胞内信号结构域(如 Lck 和 CD28)连接,scTv 能够在缺乏 CD3 亚基或共受体的情况下激活功能性 T 细胞反应,并避免与内源性 TCR 错配。通过引入 scTv,这种转导的 T 细胞可以独立于 CD3 亚基对靶向抗原作出反应,而转导的 T 细胞不会获得任何新的、定义不明确且潜在危险的特异性。

相似文献

引用本文的文献

6
Emerging Strategies in TCR-Engineered T Cells.T 细胞受体工程化细胞中的新兴策略。
Front Immunol. 2022 Mar 30;13:850358. doi: 10.3389/fimmu.2022.850358. eCollection 2022.
10
TCR-T Immunotherapy: The Challenges and Solutions.TCR-T免疫疗法:挑战与解决方案
Front Oncol. 2022 Jan 25;11:794183. doi: 10.3389/fonc.2021.794183. eCollection 2021.

本文引用的文献

3
Mixed T cell receptor dimers harbor potentially harmful neoreactivity.混合 T 细胞受体二聚体具有潜在的有害新反应性。
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10972-7. doi: 10.1073/pnas.1005802107. Epub 2010 Jun 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验